aluates Reports

$ 0.0

Automative

Global Cell Immunotherapy Platform Market Research Report 2026

Published Date: 2026-01-26

Report Code: QYRE-Auto-30K18328

Global Cell Immunotherapy Platform Market Research Report 2024

BUY CHAPTERS

Global Cell Immunotherapy Platform Market Research Report 2026

Code: QYRE-Auto-30K18328

Report

2026-01-26

Pages:110

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Kite Pharma

Novartis

Bristol–Myers Squibb

Gilead Sciences

Bluebird bio

Celyad Oncology

Autolus Therapeutics

Legend Biotech

Celltrion

Cell Immunotherapy Platform Market Size

The global Cell Immunotherapy Platform market was valued at US$ 3537 million in 2025 and is anticipated to reach US$ 10780 million by 2032, at a CAGR of 17.5% from 2026 to 2032.

Cell Immunotherapy Platform Market

The cell immunotherapy platform is a technology platform that uses the patient's own or donor's immune cells, which are cultured, activated, modified or amplified in vitro and then reinfused into the body to treat diseases. The platform activates or enhances the function of the immune system, enabling it to recognize and attack tumor cells, viral infections or other abnormal cells. Common cell immunotherapy methods include CAR-T cell therapy, T cell therapy and dendritic cell vaccines. This platform provides new treatment ideas and means for the treatment of cancer, autoimmune diseases, etc.

The North American market for Cell Immunotherapy Platform is projected to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The Asia-Pacific market for Cell Immunotherapy Platform is projected to rise from US$ million in 2025 to US$ million by 2032, at a CAGR of % over 2026–2032.

The global market for Cell Immunotherapy Platform in Immunotherapy Industry is estimated to increase from US$ million in 2025 to US$ million by 2032, at a CAGR of % from 2026 to 2032.

Major global companies of Cell Immunotherapy Platform include Kite Pharma, Novartis, Bristol Myers Squibb, Gilead Sciences, Bluebird Bio, Celyad Oncology, Autolus Therapeutics, Legend Biotech, Celltrion, etc. In 2025, the world's top three vendors accounted for approximately % of revenue.

This report delivers a comprehensive overview of the global Cell Immunotherapy Platform market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cell Immunotherapy Platform. The Cell Immunotherapy Platform market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.

The report segments the global Cell Immunotherapy Platform market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.

This report will assist Cell Immunotherapy Platform manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.

Market Segmentation

Scope of Cell Immunotherapy Platform Market Report

Report Metric	Details
Report Name	Cell Immunotherapy Platform Market
Accounted market size in 2025	US$ 3537 million
Forecasted market size in 2032	US$ 10780 million
CAGR	17.5%
Base Year	2025
Forecasted years	2026 - 2032
Segment by Type	Autologous Immune Cell Therapy Allogeneic Immune Cell Therapy
Segment by Application	Immunotherapy Industry Biopharmaceutical Industry Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Kite Pharma, Novartis, Bristol Myers Squibb, Gilead Sciences, Bluebird Bio, Celyad Oncology, Autolus Therapeutics, Legend Biotech, Celltrion
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Cell Immunotherapy Platform companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.

FAQ for this report

How fast is Cell Immunotherapy Platform Market growing?

Ans: The Cell Immunotherapy Platform Market witnessing a CAGR of 17.5% during the forecast period 2026-2032.

What is the Cell Immunotherapy Platform Market size in 2032?

Ans: The Cell Immunotherapy Platform Market size in 2032 will be US$ 10780 million.

Who are the main players in the Cell Immunotherapy Platform Market report?

Ans: The main players in the Cell Immunotherapy Platform Market are Kite Pharma, Novartis, Bristol Myers Squibb, Gilead Sciences, Bluebird Bio, Celyad Oncology, Autolus Therapeutics, Legend Biotech, Celltrion

What are the Application segmentation covered in the Cell Immunotherapy Platform Market report?

Ans: The Applications covered in the Cell Immunotherapy Platform Market report are Immunotherapy Industry, Biopharmaceutical Industry, Others

What are the Type segmentation covered in the Cell Immunotherapy Platform Market report?

Ans: The Types covered in the Cell Immunotherapy Platform Market report are Autologous Immune Cell Therapy, Allogeneic Immune Cell Therapy

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Cell Immunotherapy Platform Market Size Growth Rate by Type: 2021 vs 2025 vs 2032

1.2.2 Autologous Immune Cell Therapy

1.2.3 Allogeneic Immune Cell Therapy

1.3 Market by Application

1.3.1 Global Cell Immunotherapy Platform Market Growth by Application: 2021 vs 2025 vs 2032

1.3.2 Immunotherapy Industry

1.3.3 Biopharmaceutical Industry

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Cell Immunotherapy Platform Market Perspective (2021–2032)

2.2 Global Cell Immunotherapy Platform Growth Trends by Region

2.2.1 Global Cell Immunotherapy Platform Market Size by Region: 2021 vs 2025 vs 2032

2.2.2 Cell Immunotherapy Platform Historic Market Size by Region (2021–2026)

2.2.3 Cell Immunotherapy Platform Forecasted Market Size by Region (2027–2032)

2.3 Cell Immunotherapy Platform Market Dynamics

2.3.1 Cell Immunotherapy Platform Industry Trends

2.3.2 Cell Immunotherapy Platform Market Drivers

2.3.3 Cell Immunotherapy Platform Market Challenges

2.3.4 Cell Immunotherapy Platform Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Cell Immunotherapy Platform Players by Revenue

3.1.1 Global Top Cell Immunotherapy Platform Players by Revenue (2021–2026)

3.1.2 Global Cell Immunotherapy Platform Revenue Market Share by Players (2021–2026)

3.2 Global Top Cell Immunotherapy Platform Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)

3.3 Global Key Players Ranking by Cell Immunotherapy Platform Revenue

3.4 Global Cell Immunotherapy Platform Market Concentration Ratio

3.4.1 Global Cell Immunotherapy Platform Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Cell Immunotherapy Platform Revenue in 2025

3.5 Global Key Players of Cell Immunotherapy Platform Head Offices and Areas Served

3.6 Global Key Players of Cell Immunotherapy Platform, Products and Applications

3.7 Global Key Players of Cell Immunotherapy Platform, Date of General Availability (GA)

3.8 Mergers and Acquisitions, Expansion Plans

4 Cell Immunotherapy Platform Breakdown Data by Type

4.1 Global Cell Immunotherapy Platform Historic Market Size by Type (2021–2026)

4.2 Global Cell Immunotherapy Platform Forecasted Market Size by Type (2027–2032)

5 Cell Immunotherapy Platform Breakdown Data by Application

5.1 Global Cell Immunotherapy Platform Historic Market Size by Application (2021–2026)

5.2 Global Cell Immunotherapy Platform Forecasted Market Size by Application (2027–2032)

6 North America

6.1 North America Cell Immunotherapy Platform Market Size (2021–2032)

6.2 North America Cell Immunotherapy Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

6.3 North America Cell Immunotherapy Platform Market Size by Country (2021–2026)

6.4 North America Cell Immunotherapy Platform Market Size by Country (2027–2032)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Cell Immunotherapy Platform Market Size (2021–2032)

7.2 Europe Cell Immunotherapy Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

7.3 Europe Cell Immunotherapy Platform Market Size by Country (2021–2026)

7.4 Europe Cell Immunotherapy Platform Market Size by Country (2027–2032)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Cell Immunotherapy Platform Market Size (2021–2032)

8.2 Asia-Pacific Cell Immunotherapy Platform Market Growth Rate by Region: 2021 vs 2025 vs 2032

8.3 Asia-Pacific Cell Immunotherapy Platform Market Size by Region (2021–2026)

8.4 Asia-Pacific Cell Immunotherapy Platform Market Size by Region (2027–2032)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Cell Immunotherapy Platform Market Size (2021–2032)

9.2 Latin America Cell Immunotherapy Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

9.3 Latin America Cell Immunotherapy Platform Market Size by Country (2021–2026)

9.4 Latin America Cell Immunotherapy Platform Market Size by Country (2027–2032)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Cell Immunotherapy Platform Market Size (2021–2032)

10.2 Middle East & Africa Cell Immunotherapy Platform Market Growth Rate by Country: 2021 vs 2025 vs 2032

10.3 Middle East & Africa Cell Immunotherapy Platform Market Size by Country (2021–2026)

10.4 Middle East & Africa Cell Immunotherapy Platform Market Size by Country (2027–2032)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Kite Pharma

11.1.1 Kite Pharma Company Details

11.1.2 Kite Pharma Business Overview

11.1.3 Kite Pharma Cell Immunotherapy Platform Introduction

11.1.4 Kite Pharma Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.1.5 Kite Pharma Recent Development

11.2 Novartis

11.2.1 Novartis Company Details

11.2.2 Novartis Business Overview

11.2.3 Novartis Cell Immunotherapy Platform Introduction

11.2.4 Novartis Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.2.5 Novartis Recent Development

11.3 Bristol Myers Squibb

11.3.1 Bristol Myers Squibb Company Details

11.3.2 Bristol Myers Squibb Business Overview

11.3.3 Bristol Myers Squibb Cell Immunotherapy Platform Introduction

11.3.4 Bristol Myers Squibb Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.3.5 Bristol Myers Squibb Recent Development

11.4 Gilead Sciences

11.4.1 Gilead Sciences Company Details

11.4.2 Gilead Sciences Business Overview

11.4.3 Gilead Sciences Cell Immunotherapy Platform Introduction

11.4.4 Gilead Sciences Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.4.5 Gilead Sciences Recent Development

11.5 Bluebird Bio

11.5.1 Bluebird Bio Company Details

11.5.2 Bluebird Bio Business Overview

11.5.3 Bluebird Bio Cell Immunotherapy Platform Introduction

11.5.4 Bluebird Bio Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.5.5 Bluebird Bio Recent Development

11.6 Celyad Oncology

11.6.1 Celyad Oncology Company Details

11.6.2 Celyad Oncology Business Overview

11.6.3 Celyad Oncology Cell Immunotherapy Platform Introduction

11.6.4 Celyad Oncology Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.6.5 Celyad Oncology Recent Development

11.7 Autolus Therapeutics

11.7.1 Autolus Therapeutics Company Details

11.7.2 Autolus Therapeutics Business Overview

11.7.3 Autolus Therapeutics Cell Immunotherapy Platform Introduction

11.7.4 Autolus Therapeutics Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.7.5 Autolus Therapeutics Recent Development

11.8 Legend Biotech

11.8.1 Legend Biotech Company Details

11.8.2 Legend Biotech Business Overview

11.8.3 Legend Biotech Cell Immunotherapy Platform Introduction

11.8.4 Legend Biotech Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.8.5 Legend Biotech Recent Development

11.9 Celltrion

11.9.1 Celltrion Company Details

11.9.2 Celltrion Business Overview

11.9.3 Celltrion Cell Immunotherapy Platform Introduction

11.9.4 Celltrion Revenue in Cell Immunotherapy Platform Business (2021–2026)

11.9.5 Celltrion Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Kite Pharma

Novartis

Bristol–Myers Squibb

Gilead Sciences

Bluebird bio

Celyad Oncology

Autolus Therapeutics

Legend Biotech

Celltrion

List of Tables

Table 1. Global Cell Immunotherapy Platform Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032

Table 2. Key Players of Autologous Immune Cell Therapy

Table 3. Key Players of Allogeneic Immune Cell Therapy

Table 4. Global Cell Immunotherapy Platform Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032

Table 5. Global Cell Immunotherapy Platform Market Size by Region (US$ Million): 2021 vs 2025 vs 2032

Table 6. Global Cell Immunotherapy Platform Market Size by Region (US$ Million), 2021–2026

Table 7. Global Cell Immunotherapy Platform Market Share by Region (2021–2026)

Table 8. Global Cell Immunotherapy Platform Forecasted Market Size by Region (US$ Million), 2027–2032

Table 9. Global Cell Immunotherapy Platform Market Share by Region (2027–2032)

Table 10. Cell Immunotherapy Platform Market Trends

Table 11. Cell Immunotherapy Platform Market Drivers

Table 12. Cell Immunotherapy Platform Market Challenges

Table 13. Cell Immunotherapy Platform Market Restraints

Table 14. Global Cell Immunotherapy Platform Revenue by Players (US$ Million), 2021–2026

Table 15. Global Cell Immunotherapy Platform Market Share by Players (2021–2026)

Table 16. Global Top Cell Immunotherapy Platform Players by Tier (Tier 1, Tier 2, and Tier 3), based on Cell Immunotherapy Platform Revenue, 2025

Table 17. Ranking of Global Top Cell Immunotherapy Platform Companies by Revenue (US$ Million) in 2025

Table 18. Global 5 Largest Players Market Share by Cell Immunotherapy Platform Revenue (CR5 and HHI), 2021–2026

Table 19. Global Key Players of Cell Immunotherapy Platform, Headquarters and Area Served

Table 20. Global Key Players of Cell Immunotherapy Platform, Products and Applications

Table 21. Global Key Players of Cell Immunotherapy Platform, Date of General Availability (GA)

Table 22. Mergers and Acquisitions, Expansion Plans

Table 23. Global Cell Immunotherapy Platform Market Size by Type (US$ Million), 2021–2026

Table 24. Global Cell Immunotherapy Platform Revenue Market Share by Type (2021–2026)

Table 25. Global Cell Immunotherapy Platform Forecasted Market Size by Type (US$ Million), 2027–2032

Table 26. Global Cell Immunotherapy Platform Revenue Market Share by Type (2027–2032)

Table 27. Global Cell Immunotherapy Platform Market Size by Application (US$ Million), 2021–2026

Table 28. Global Cell Immunotherapy Platform Revenue Market Share by Application (2021–2026)

Table 29. Global Cell Immunotherapy Platform Forecasted Market Size by Application (US$ Million), 2027–2032

Table 30. Global Cell Immunotherapy Platform Revenue Market Share by Application (2027–2032)

Table 31. North America Cell Immunotherapy Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 32. North America Cell Immunotherapy Platform Market Size by Country (US$ Million), 2021–2026

Table 33. North America Cell Immunotherapy Platform Market Size by Country (US$ Million), 2027–2032

Table 34. Europe Cell Immunotherapy Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 35. Europe Cell Immunotherapy Platform Market Size by Country (US$ Million), 2021–2026

Table 36. Europe Cell Immunotherapy Platform Market Size by Country (US$ Million), 2027–2032

Table 37. Asia-Pacific Cell Immunotherapy Platform Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032

Table 38. Asia-Pacific Cell Immunotherapy Platform Market Size by Region (US$ Million), 2021–2026

Table 39. Asia-Pacific Cell Immunotherapy Platform Market Size by Region (US$ Million), 2027–2032

Table 40. Latin America Cell Immunotherapy Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 41. Latin America Cell Immunotherapy Platform Market Size by Country (US$ Million), 2021–2026

Table 42. Latin America Cell Immunotherapy Platform Market Size by Country (US$ Million), 2027–2032

Table 43. Middle East & Africa Cell Immunotherapy Platform Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032

Table 44. Middle East & Africa Cell Immunotherapy Platform Market Size by Country (US$ Million), 2021–2026

Table 45. Middle East & Africa Cell Immunotherapy Platform Market Size by Country (US$ Million), 2027–2032

Table 46. Kite Pharma Company Details

Table 47. Kite Pharma Business Overview

Table 48. Kite Pharma Cell Immunotherapy Platform Product

Table 49. Kite Pharma Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 50. Kite Pharma Recent Development

Table 51. Novartis Company Details

Table 52. Novartis Business Overview

Table 53. Novartis Cell Immunotherapy Platform Product

Table 54. Novartis Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 55. Novartis Recent Development

Table 56. Bristol Myers Squibb Company Details

Table 57. Bristol Myers Squibb Business Overview

Table 58. Bristol Myers Squibb Cell Immunotherapy Platform Product

Table 59. Bristol Myers Squibb Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 60. Bristol Myers Squibb Recent Development

Table 61. Gilead Sciences Company Details

Table 62. Gilead Sciences Business Overview

Table 63. Gilead Sciences Cell Immunotherapy Platform Product

Table 64. Gilead Sciences Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 65. Gilead Sciences Recent Development

Table 66. Bluebird Bio Company Details

Table 67. Bluebird Bio Business Overview

Table 68. Bluebird Bio Cell Immunotherapy Platform Product

Table 69. Bluebird Bio Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 70. Bluebird Bio Recent Development

Table 71. Celyad Oncology Company Details

Table 72. Celyad Oncology Business Overview

Table 73. Celyad Oncology Cell Immunotherapy Platform Product

Table 74. Celyad Oncology Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 75. Celyad Oncology Recent Development

Table 76. Autolus Therapeutics Company Details

Table 77. Autolus Therapeutics Business Overview

Table 78. Autolus Therapeutics Cell Immunotherapy Platform Product

Table 79. Autolus Therapeutics Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 80. Autolus Therapeutics Recent Development

Table 81. Legend Biotech Company Details

Table 82. Legend Biotech Business Overview

Table 83. Legend Biotech Cell Immunotherapy Platform Product

Table 84. Legend Biotech Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 85. Legend Biotech Recent Development

Table 86. Celltrion Company Details

Table 87. Celltrion Business Overview

Table 88. Celltrion Cell Immunotherapy Platform Product

Table 89. Celltrion Revenue in Cell Immunotherapy Platform Business (US$ Million), 2021–2026

Table 90. Celltrion Recent Development

Table 91. Research Programs/Design for This Report

Table 92. Key Data Information from Secondary Sources

Table 93. Key Data Information from Primary Sources

Table 94. Authors List of This Report

List of Figures

Figure 1. Cell Immunotherapy Platform Picture

Figure 2. Global Cell Immunotherapy Platform Market Size Comparison by Type (US$ Million), 2021–2032

Figure 3. Global Cell Immunotherapy Platform Market Share by Type: 2025 vs 2032

Figure 4. Autologous Immune Cell Therapy Features

Figure 5. Allogeneic Immune Cell Therapy Features

Figure 6. Global Cell Immunotherapy Platform Market Size by Application (US$ Million), 2021–2032

Figure 7. Global Cell Immunotherapy Platform Market Share by Application: 2025 vs 2032

Figure 8. Immunotherapy Industry Case Studies

Figure 9. Biopharmaceutical Industry Case Studies

Figure 10. Others Case Studies

Figure 11. Cell Immunotherapy Platform Report Years Considered

Figure 12. Global Cell Immunotherapy Platform Market Size (US$ Million), Year-over-Year: 2021–2032

Figure 13. Global Cell Immunotherapy Platform Market Size, (US$ Million), 2021 vs 2025 vs 2032

Figure 14. Global Cell Immunotherapy Platform Market Share by Region: 2025 vs 2032

Figure 15. Global Cell Immunotherapy Platform Market Share by Players in 2025

Figure 16. Global Cell Immunotherapy Platform Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 17. The Top 10 and 5 Players Market Share by Cell Immunotherapy Platform Revenue in 2025

Figure 18. North America Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 19. North America Cell Immunotherapy Platform Market Share by Country (2021–2032)

Figure 20. United States Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 21. Canada Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 22. Europe Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 23. Europe Cell Immunotherapy Platform Market Share by Country (2021–2032)

Figure 24. Germany Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 25. France Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 26. U.K. Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 27. Italy Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 28. Russia Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 29. Ireland Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 30. Asia-Pacific Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 31. Asia-Pacific Cell Immunotherapy Platform Market Share by Region (2021–2032)

Figure 32. China Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 33. Japan Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 34. South Korea Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 35. Southeast Asia Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 36. India Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 37. Australia & New Zealand Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 38. Latin America Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 39. Latin America Cell Immunotherapy Platform Market Share by Country (2021–2032)

Figure 40. Mexico Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 41. Brazil Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 42. Middle East & Africa Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 43. Middle East & Africa Cell Immunotherapy Platform Market Share by Country (2021–2032)

Figure 44. Israel Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 45. Saudi Arabia Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 46. UAE Cell Immunotherapy Platform Market Size YoY Growth (US$ Million), 2021–2032

Figure 47. Kite Pharma Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 48. Novartis Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 49. Bristol Myers Squibb Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 50. Gilead Sciences Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 51. Bluebird Bio Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 52. Celyad Oncology Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 53. Autolus Therapeutics Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 54. Legend Biotech Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 55. Celltrion Revenue Growth Rate in Cell Immunotherapy Platform Business (2021–2026)

Figure 56. Bottom-up and Top-down Approaches for This Report

Figure 57. Data Triangulation

Figure 58. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic

$2900

Single User License

Multi User

Electronic

$4350

Multi User License

Enterprise License

Electronic

$5800

Enterprise License

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global T Cell Immunotherapy Market Research Report 2025

Global Cell Therapy Manufacturing Platform Market Research Report 2024

Global TCR T Cellular Immunotherapy Market Research Report 2024

Global Immuno Cell Therapy Market Research Report 2024

Global Cancer Immunotherapy Drugs Market Research Report 2024

Global CAR T Cell Immunotherapy Market Insights Forecast to 2030

Global Cancer Immunosuppressant Treatment Market Research Report 2024

Global Cancer Immuno Personalized Medicine Market Research Report 2024

Global Tumor Immune Cell Therapy Market Research Report 2024

Global Immunosuppressants in Cancer Therapy Market Research Report 2024

Global Immunotherapy Drugs Market Research Report 2024

Global Cell Based Immunotherapy Market Research Report 2024

Immune Cell Therapy Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Adoptive Cell Therapy Market Insights Forecast to 2030

Global Immunotherapeutic Drugs Market Insights Forecast to 2030

Global Cell Therapy Market Insights Forecast to 2030

Immuno oncology Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Autologous CAR T Cell Therapy Market Research Report 2024

Global Immunocell Therapy Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions